Insulin resistance and PCOS: chicken or egg?
The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
PCOS is a common and heterogeneous endocrine disorder in women of reproductive age, frequently associated with metabolic abnormalities. It was estimated that about 75% of these subjects have an impairment of insulin action, as measured by gold standard methods. While the relationship between insulin resistance and PCOS is consistently shown by a number of studies, the mechanisms underlying its primary origin still remains an unsolved issue. Insulin resistance and the associated hyperinsulinemia can induce both the endocrine and reproductive traits of PCOS. However, androgen excess, in turn, can impair insulin action, directly and/or through several changes occurring in different tissues. Body fat excess, which is another common feature in these women, can contribute to worsening the whole picture. Nevertheless, insulin resistance may also be found in many normal-weight individuals. Endocrine and metabolic abnormalities can develop in different moments, and probably there is fetal programming of these alterations. However, a number of vicious circles, with bidirectional relationships between androgen excess and insulin resistance, and with the contribution of several other factors, make it extremely difficult to understand where this process really originates. This review summarizes available evidence on this topic, in order to better understand the complex relationships linking hyperandrogenism and impaired insulin action in women with PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using gold standard procedures, it was estimated that approximately 75% of patients with PCOS had insulin resistance and that the endocrine and reproductive characteristics of PCOS can be brought on by insulin resistance [27].”
From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [27]
In the citing paper
“Using gold standard procedures, it was estimated that approximately 75% of patients with PCOS had insulin resistance and that the endocrine and reproductive characteristics of PCOS can be brought on by insulin resistance [27].”
From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [27]
In the citing paper
“Consequently, HOMA-IR was selected in this study as the major end point as it plays a significant role in the onset and progression of PCOS.”
From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [27]
In the citing paper
“Insulin levels, which mainly drive these surrogate indexes, depend on several factors, not only insulin sensitivity and glucose levels. In particular, obesity, age, androgen levels, metabolism and clearance of insulin, and enzymatic degradation of the insulin–receptor complex are perhaps more valuable than insulin itself [44].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [44]
In the citing paper
“The result of all the processes described above is impaired glucose transport into cells by insulin-dependent membrane GLUT 4 transporters, reduced glycogen synthesis and decreased inhibition of hepatic gluconeogenesis. This leads to hyperglycemia and to compensatory hyperinsulinemia.”
From The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome (2022) · cites this paper as [61]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358 · cited 1×
“Based on the generally adopted Rotterdam diagnostic criteria, established in a workshop consensus of the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embriology (ESHRE) [1], it was estimated that its prevalence is at least 10% [2].”
MethodMoran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Biological Actions of Androgens
MOORADIAN, A. D., MORLEY, J. E., & KORENMAN, S. G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-1 · Cited by 1,080
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931
Insulin Degradation: Progress and Potential*
Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0349 · Cited by 871
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747
Using human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14956 · Cited by 699
Tang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub5 · Cited by 698
Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6293 · Cited by 660
Self-citationHeritability of polycystic ovary syndrome in a Dutch twin-family study
Vink, J. M., Sadrzadeh, S., Lambalk, C. B., & Boomsma, D. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1494 · Cited by 647
Day, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007813 · Cited by 619
Nestler, J. E., Jakubowicz, D. J., Falcon de Vargas, A., Brik, C., Quintero, N., & Medina, F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4886 · Cited by 617 · cited 1×
“Insulin stimulates androgen secretion in cultured theca cells from healthy subjects, and this phenomenon is strongly enhanced in cells from women with PCOS [76], suggesting intrinsic abnormalities.”
BackgroundDunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561
Tata, B., Mimouni, N. E. H., Barbotin, A.-L., Malone, S. A., Loyens, A., Pigny, P., Dewailly, D., Catteau-Jonard, S., Sundström-Poromaa, I., Piltonen, T. T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0035-5 · Cited by 434
Cassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016) · Human Reproduction · doi:10.1093/humrep/dew243 · Cited by 415
Sir-Petermann, T. (2002) · Human Reproduction · doi:10.1093/humrep/17.10.2573 · Cited by 412
Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
Barber, T. M., Hanson, P., Weickert, M. O., & Franks, S. (2019) · Clinical Medicine Insights: Reproductive Health · doi:10.1177/1179558119874042 · Cited by 411
Induction of insulin resistance by androgens and estrogens
Polderman, K. H. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.1.265 · Cited by 380 · cited 1×
“In this regard, a couple of studies, carried out using multi-step hyperinsulinemic glucose clamps, showed a rapid onset of insulin resistance after supraphysiological androgen administration in women [82, 83].”
ResultMannerås-Holm, L., Leonhardt, H., Kullberg, J., Jennische, E., Odén, A., Holm, G., Hellström, M., Lönn, L., Olivecrona, G., Stener-Victorin, E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1290 · Cited by 369
Carmina, E., Bucchieri, S., Esposito, A., Del Puente, A., Mansueto, P., Orio, F., Di Fede, G., & Rini, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2725 · Cited by 317
Holte, J. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1052 · Cited by 290 · cited 1×
“Remarkably, there is evidence that the effect of increased BMI in worsening insulin resistance may be proportionally more evident in PCOS women, as compared with control women [17, 18].”
Background11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome
O’Reilly, M. W., Kempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K.-H., & Arlt, W. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3285 · Cited by 267
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262
Self-citationSir-Petermann, T., Codner, E., Pérez, V., Echiburú, B., Maliqueo, M., Ladrón de Guevara, A., Preisler, J., Crisosto, N., Sánchez, F., Cassorla, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2836 · Cited by 260
Moghetti, P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.952 · Cited by 245 · cited 1×
“However, interestingly, this alteration improved, at least in part, after different treatments aimed at reducing either androgen levels or androgen action, which supports an effect of hyperandrogenism on insulin sensitivity [84].”
BackgroundSelf-citationTurcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1181 · Cited by 231
Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes
Gambineri, A., Patton, L., Altieri, P., Pagotto, U., Pizzi, C., Manzoli, L., & Pasquali, R. (2012) · Diabetes · doi:10.2337/db11-1360 · Cited by 225
Dumesic, D. A., Akopians, A. L., Madrigal, V. K., Ramirez, E., Margolis, D. J., Sarma, M. K., Thomas, A. M., Grogan, T. R., Haykal, R., Schooler, T. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2586 · Cited by 222
O’Reilly, M. W., Kempegowda, P., Walsh, M., Taylor, A. E., Manolopoulos, K. N., Allwood, J. W., Semple, R. K., Hebenstreit, D., Dunn, W. B., Tomlinson, J. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00947 · Cited by 215 · cited 2×
“These authors reported that PCOS women had increased mRNA expression, in this tissue, of AKR1C3, the key enzyme synthesizing testosterone from its precursor androstenedione [88].”
BackgroundMoghetti, P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.881 · Cited by 196 · cited 1×
“In addition, adrenal androgen secretion, under ACTH stimulation, is also greater when stimulation is carried out during hyperinsulinemia, induced by the glucose clamp procedure, than at baseline insulin levels [78, 79].”
BackgroundSelf-citationThe prevalence of polycystic ovaries in women with type 2 diabetes mellitus
Conn, J. J., Jacobs, H. S., & Conway, G. S. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00884.x · Cited by 186
New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins
Walters, K. A., Gilchrist, R. B., Ledger, W. L., Teede, H. J., Handelsman, D. J., & Campbell, R. E. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.08.005 · Cited by 186
Corbould, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07070 · Cited by 184
Effects of testosterone on muscle insulin sensitivity and morphology in female rats
Holmang, A., Svedberg, J., Jennische, E., & Bjorntorp, P. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.259.4.e555 · Cited by 178 · cited 1×
“Interestingly, in this model, skeletal muscle fibres had shifted toward a less insulin sensitive type 2 phenotype and there was also a reduction in muscle capillary density [85].”
BackgroundWu, S., Divall, S., Nwaopara, A., Radovick, S., Wondisford, F., Ko, C., & Wolfe, A. (2014) · Diabetes · doi:10.2337/db13-1514 · Cited by 176
Ek, I., Arner, P., Rydén, M., Holm, C., Thörne, A., Hoffstedt, J., & Wahrenberg, H. (2002) · Diabetes · doi:10.2337/diabetes.51.2.484 · Cited by 174
The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome
Kakoly, N. S., Earnest, A., Teede, H. J., Moran, L. J., & Joham, A. E. (2019) · Diabetes Care · doi:10.2337/dc18-1738 · Cited by 174
Lizneva, D., Kirubakaran, R., Mykhalchenko, K., Suturina, L., Chernukha, G., Diamond, M. P., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.07.1121 · Cited by 171 · cited 1×
“Some studies have suggested that the association between obesity and PCOS may be inflated by significant referral bias [24].”
BackgroundNelson-Degrave, V. L., Wickenheisser, J. K., Hendricks, K. L., Asano, T., Fujishiro, M., Legro, R. S., Kimball, S. R., Strauss, J. F., & McAllister, J. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0178 · Cited by 167
Enhanced Mitogenic Signaling in Skeletal Muscle of Women With Polycystic Ovary Syndrome
Corbould, A., Zhao, H., Mirzoeva, S., Aird, F., & Dunaif, A. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0453 · Cited by 166
Tosi, F., Bonora, E., & Moghetti, P. (2017) · Human Reproduction · doi:10.1093/humrep/dex308 · Cited by 163
Self-citationThe role of MiRNA in polycystic ovary syndrome (PCOS)
Chen, B., Xu, P., Wang, J., & Zhang, C. (2019) · Gene · doi:10.1016/j.gene.2019.04.082 · Cited by 156
Glintborg, D., Hass Rubin, K., Nybo, M., Abrahamsen, B., & Andersen, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1108 · Cited by 154
Rege, J., Turcu, A., Kasa-Vubu, J. Z., Lerario, A. M., Auchus, G. C., Auchus, R. J., Smith, J. M., White, P. C., & Rainey, W. E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00736 · Cited by 154 · cited 3×
“This could be biologically relevant, as recent data in cultured cells transfected with the androgen receptor showed that 11-ketotestosterone may effectively bind and activate this receptor, with a potency of action that, in this in vitro model, was about 75% as compared with testosterone [41].”
BackgroundPrevalence of Polycystic Ovary Syndrome Among Premenopausal Women With Type 2 Diabetes
Peppard, H. R., Marfori, J., Iuorno, M. J., & Nestler, J. E. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1050 · Cited by 147
Højlund, K., Glintborg, D., Andersen, N. R., Birk, J. B., Treebak, J. T., Frøsig, C., Beck-Nielsen, H., & Wojtaszewski, J. F. P. (2008) · Diabetes · doi:10.2337/db07-0706 · Cited by 143
Hyperandrogenic origins of polycystic ovary syndrome-Implications for Pathophysiology and Therapy
Abbott, D. H., Dumesic, D. A., & Levine, J. E. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1576522 · Cited by 131
Hiam, D., Moreno-Asso, A., Teede, H. J., Laven, J. S. E., Stepto, N. K., Moran, L. J., & Gibson-Helm, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101606 · Cited by 126
Brower, M. A., Hai, Y., Jones, M. R., Guo, X., Chen, Y. D. I., Rotter, J. I., Krauss, R. M., Legro, R. S., Azziz, R., & Goodarzi, M. O. (2019) · Human Reproduction · doi:10.1093/humrep/dey343 · Cited by 115
Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies
Malek, R., Chong, A. Y., Lupsa, B. C., Lungu, A. O., Cochran, E. K., Soos, M. A., Semple, R. K., Balow, J. E., & Gorden, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0167 · Cited by 114
DNA methylation in the pathogenesis of polycystic ovary syndrome
Vázquez-Martínez, E. R., Gómez-Viais, Y. I., García-Gómez, E., Reyes-Mayoral, C., Reyes-Muñoz, E., Camacho-Arroyo, I., & Cerbón, M. (2019) · Reproduction · doi:10.1530/rep-18-0449 · Cited by 106
Effects of Methyltestosterone on Insulin Secretion and Sensitivity In Women1
Diamond, M. P., Grainger, D., Diamond, M. C., Sherwin, R. S., & DeFronzo, R. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5333 · Cited by 104 · cited 1×
“In this regard, a couple of studies, carried out using multi-step hyperinsulinemic glucose clamps, showed a rapid onset of insulin resistance after supraphysiological androgen administration in women [82, 83].”
ResultMechanisms of intergenerational transmission of polycystic ovary syndrome
Dumesic, D. A., Hoyos, L. R., Chazenbalk, G. D., Naik, R., Padmanabhan, V., & Abbott, D. H. (2020) · Reproduction · doi:10.1530/rep-19-0197 · Cited by 101
Sam, S., Legro, R. S., Essah, P. A., Apridonidze, T., & Dunaif, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602025103 · Cited by 96
Nilsson, E., Benrick, A., Kokosar, M., Krook, A., Lindgren, E., Källman, T., Martis, M. M., Højlund, K., Ling, C., & Stener-Victorin, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00935 · Cited by 93
Tosi, F., Negri, C., Perrone, F., Dorizzi, R., Castello, R., Bonora, E., & Moghetti, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2939 · Cited by 90
Self-citationWang, X.-X., Wei, J.-Z., Jiao, J., Jiang, S.-Y., Yu, D.-H., & Li, D. (2014) · Oncotarget · doi:10.18632/oncotarget.2224 · Cited by 90
Murri, M., Insenser, M., Fernández-Durán, E., San-Millán, J. L., Luque-Ramírez, M., & Escobar-Morreale, H. F. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.011 · Cited by 88
Androgen Excess in Pancreatic β Cells and Neurons Predisposes Female Mice to Type 2 Diabetes
Navarro, G., Allard, C., Morford, J. J., Xu, W., Liu, S., Molinas, A. J. R., Butcher, S. M., Fine, N. H. F., Blandino-Rosano, M., Sure, V. N., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98607 · Cited by 80
Hansen, S. L., Svendsen, P. F., Jeppesen, J. F., Hoeg, L. D., Andersen, N. R., Kristensen, J. M., Nilas, L., Lundsgaard, A.-M., Wojtaszewski, J. F. P., Madsbad, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01771 · Cited by 76
González, F., Nair, K. S., Daniels, J. K., Basal, E., & Schimke, J. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00416.2011 · Cited by 70
Tosi, F., Di Sarra, D., Kaufman, J.-M., Bonin, C., Moretta, R., Bonora, E., Zanolin, E., & Moghetti, P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2786 · Cited by 70
Self-citationThe Pancreatic β Cells in Human Type 2 Diabetes
Marchetti, P., Bugliani, M., Boggi, U., Masini, M., & Marselli, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_22 · Cited by 68
Implications of Androgen Assay Accuracy in the Phenotyping of Women With Polycystic Ovary Syndrome
Tosi, F., Fiers, T., Kaufman, J.-M., Dall'Alda, M., Moretta, R., Giagulli, V. A., Bonora, E., & Moghetti, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2807 · Cited by 67
Self-citationZhao, Y., Xu, Y., Wang, X., Xu, L., Chen, J., Gao, C., Wu, C., Pan, D., Zhang, Q., Zhou, J., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa125 · Cited by 67
Joo, Y. Y., Actkins, K., Pacheco, J. A., Basile, A. O., Carroll, R., Crosslin, D. R., Day, F., Denny, J. C., Velez Edwards, D. R., Hakonarson, H., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz326 · Cited by 63
New perspectives on the definition and management of polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0832-1 · Cited by 59
Lambertini, L., Saul, S. R., Copperman, A. B., Hammerstad, S. S., Yi, Z., Zhang, W., Tomer, Y., & Kase, N. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00352 · Cited by 57
Che, Q., Liu, M., Xu, J., Liu, Y., Cao, X., Dong, X., & Liu, S. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.02.023 · Cited by 53
Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women
Tosi, F., Negri, C., Brun, E., Castello, R., Faccini, G., Bonora, E., Muggeo, M., Toscano, V., & Moghetti, P. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0782 · Cited by 52
Self-citationEchiburú, B., Milagro, F. I., Crisosto, N., Pérez‐Bravo, F., Flores, C., Arpón, A., Salas‐Pérez, F., Recabarren, S. E., Sir‐Petermann, T., & Maliqueo, M. A. (2020) · Epigenetics · doi:10.1080/15592294.2020.1754674 · Cited by 51
Yilmaz, B., Vellanki, P., Ata, B., & Yildiz, B. O. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.04.024 · Cited by 50
Dulka, E. A., & Moenter, S. M. (2017) · Endocrinology · doi:10.1210/en.2017-00768 · Cited by 49
The impact of androgen actions in neurons on metabolic health and disease
Morford, J. J., Wu, S., & Mauvais‐Jarvis, F. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.001 · Cited by 48
Di Sarra, D., Tosi, F., Bonin, C., Fiers, T., Kaufman, J.-M., Signori, C., Zambotti, F., Dall'Alda, M., Caruso, B., Zanolin, M. E., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1161 · Cited by 47
Self-citationDoes a male polycystic ovarian syndrome equivalent exist?
Cannarella, R., Condorelli, R. A., Mongioì, L. M., Vignera, S. L., & Calogero, A. E. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0728-5 · Cited by 47 · cited 1×
“1 3 and depression, as well as genetic variants linked to male pattern balding, which is a putative male phenotype [54], may be causally linked to the syndrome [53].”
BackgroundBuffington, C. K., & Kitabchi, A. E. (1994) · Metabolism · doi:10.1016/0026-0495(94)90029-9 · Cited by 42
Che, Q., Liu, M., Zhang, D., Lu, Y., Xu, J., Lu, X., Cao, X., Liu, Y., Dong, X., & Liu, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa060 · Cited by 40
Zargar, A. H., Gupta, V., Wani, A. I., Masoodi, S. R., Bashir, M. I., Laway, B. A., Ganie, M. A., & Salahuddin, M. (2005) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-3-35 · Cited by 37
Keleştimur, F., Ünlühızarcı, K., Baybuga, H., Atmaca, H., Bayram, F., & Şahin, Y. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.01.019 · Cited by 37
Tosi, F., Molin, F. D., Zamboni, F., Saggiorato, E., Salvagno, G. L., Fiers, T., Kaufman, J., Bonora, E., & Moghetti, P. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa095 · Cited by 33
Self-citationRege, J., Nanba, A. T., Auchus, R. J., Ren, J., Peng, H.-M., Rainey, W. E., & Turcu, A. F. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01525 · Cited by 30
Cardoso, R. C., Burns, A., Moeller, J., Skinner, D. C., & Padmanabhan, V. (2016) · Endocrinology · doi:10.1210/en.2016-1613 · Cited by 28
Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity.
Ciaraldi, T. (2000) · PubMed · Cited by 25
Vilariño‐García, T., Pérez‐Pérez, A., Santamaría‐López, E., Prados, N., Sánchez, M. F., & Sánchez‐Margalet, V. (2020) · Endocrine Connections · doi:10.1530/ec-20-0062 · Cited by 18
Dahan, M. H., Abbasi, F., & Reaven, G. M. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01014-9 · Cited by 15
Bacchi, E., Negri, C., Di Sarra, D., Tosi, F., Tarperi, C., Moretta, R., Schena, F., Bonora, E., Kaufman, J., & Moghetti, P. (2015) · Clinical Endocrinology · doi:10.1111/cen.12855 · Cited by 10
Self-citationInsulin Resistant Syndromes in Humans
Bar, R. S., Muggeo, M., & Roth, J. (1979) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-8508-0_5 · Cited by 2
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Research works printed but not linked: 1
- Johnson T, Kaplan L, Ouyang P, Rizza P (2012) National Institutes of Health evidence-based methodology workshop on polycystic ovary syndrome. NIH EbMW reports. National Institutes of Health, Bethesda 1:1–14. https://www.prevention.nih.gov/sites/default/files/2018-06/FinalReport.pdf. Accessed 31 Mar 2020
Cited by
Role of Insulin in Health and Disease: An Update
Rahman, M. S., Hossain, K. S., Das, S., Kundu, S., Adegoke, E. O., Rahman, M. A., Hannan, M. A., Uddin, M. J., & Pang, M.-G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126403 · Cited by 472
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
“In particular, obesity, age, androgen levels, metabolism and clearance of insulin, and enzymatic degradation of the insulin–receptor complex are perhaps more valuable than insulin itself [44].”
BackgroundCalcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183
“Hyperinsulinemia leads to increased androgen production, which, in turn, may impair insulin sensitivity [98].”
BackgroundTong, C., Wu, Y., Zhang, L., & Yu, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1091147 · Cited by 157
“According to statistics, about 75% of PCOS patients develop IR, with a higher percentage of PCOS patients with obesity, and the development of PCOS is also inseparable from IR (3).”
BackgroundBednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A., & Madej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084334 · Cited by 148
“IR, the resulting hyperinsulinemia, and increased androgen levels influence each other, and it is difficult to determine which phenomenon occurs first (Figure 4) [61].”
Background
Metadata
- Authors
- Moghetti, P., & Tosi, F.
- Affiliations
- University of Verona (IT)
- Corresponding author
- Moghetti, P.
- ORCID
- Venue
- Journal of Endocrinological Investigation
- Published
- 2020-07-09
- Volume
- 44
- Issue
- 2
- Pages
- 233-244
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W3041550542
- Cited by
- 209
- References
- 92
- Citations by year
- 2026: 30 · 2025: 32 · 2024: 36 · 2023: 48 · 2022: 47 · 2021: 15 · 2020: 1
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Università degli Studi di Verona
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, insulin resistance, hyperinsulinemia, hyperandrogenism, excess body fat, fetal programming, metabolic abnormalities, reproductive endocrine disorders, pathogenesis
- MeSH terms
- Animals, Female, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.